Source
Diabetes, Obesity and Metabolism .
Takeaway
In people with type 2 diabetes, investigational once-weekly basal analogue insulins provided greater glycated haemoglobin (HbA1c) reductions, with most of the difference because of insulin icodec.
Time-in-range was also greater with the once-weeklies, without increased adverse event (AE) or hypoglycaemia risk.
Why this ...
